Table 3. Patient survival analyses.

Tumor	LRP1	LRP2	LRP4	LRP5	LRP10	LDL-R
Urothelial	p<0.0005	X	X	NS	NS	X
Breast	NS	NS	X	NS	NS	X
Colorectal	NS	X	X	NS	NS	NS
Glioblastoma	NS	X	NS	X	NS	X
Renal Cell	NS	p<0.0001	X	X	NS	X
Hepatocellular	NS	X	X	NS	p<0.005	NS
Lung	NS	X	X	NS	p<0.05	NS
Pancreatic	NS	X	X	NS	p<0.05	p<0.01
Prostate	NS	X	X	X	NS	X
Melanoma	NS	NS	X	X	NS	X

P-values are shown for statistically significant differences in patient survival associated with having tumors in which expression of the indicated LRP is in the top 25% versus the bottom 25%. Analyses that were performed that did not generate statistically significant results are marked “NS” or “not significant”. An “X” designates an analysis that was not performed.